{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-256062","form_type":"8-K","ticker":"OSRH","cik":"0001840425","company_name":"OSR Holdings, Inc.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.967372+00:00","generated_at":"2026-05-30T02:11:28.618429+00:00","sec_items":["5.03","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Stockholders approve extension of Bellevue Life Sciences SPAC deadline to Feb 2025; 44% of shares redeemed","bullets":["Charter amended to extend business combination deadline from Nov 14, 2024 to Feb 14, 2025.","Charter amended to remove net tangible asset requirement to avoid penny stock rules.","1,766,469 shares (approx. 44% of outstanding) tendered for redemption.","Five existing directors re-elected at annual meeting.","Quorum was 71.24% of outstanding shares; proposals approved overwhelmingly."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-256062","json":"https://secwatch.observer/filing/0001193125-24-256062.json","markdown":"https://secwatch.observer/filing/0001193125-24-256062.md","text":"https://secwatch.observer/filing/0001193125-24-256062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840425/000119312524256062/0001193125-24-256062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840425/000119312524256062/d812587d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:11:28.618429+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}